Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Badimon

Showing results (211-220 of 262) with videos related to

Pageof 27
Sort By:
Thrombosis and Haemostasis|December 7, 2017
Escitalopram Impairs Thrombin-Induced Platelet Response, Cytoskeletal Assembly and Activation of Associated Signalling PathwaysIrene Lopez-Vilchez, Didac Jerez-Dolz, Maribel Diaz-Ricart, et al.
Pathophysiology of Haemostasis and Thrombosis|March 12, 2008
Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosisStephen G Worthley, Gérard Helft, Roberto Corti, et al.
Circulation|February 4, 1997
Tissue factor modulates the thrombogenicity of human atherosclerotic plaquesV Toschi, R Gallo, M Lettino, et al.
The American Journal of Cardiology|July 29, 2000
In vivo demonstration of an antithrombin effect of abciximabJ A Ambrose, M Hawkey, J J Badimon, et al.
The British Journal of Cardiology|June 24, 2024
Metabolic syndrome components determine the presence of subclinical atherosclerosis in obese and overweightGustavo A Giunta, Pablo D Cutine, María F Aguiló Iztueta, et al.
Thrombosis and Haemostasis|May 24, 2000
Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effectG Dangas, D A Smith, A H Unger, et al.
The American Journal of Cardiology|September 25, 1999
Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatinG Dangas, D A Smith, J J Badimon, et al.
American Heart Journal|July 1, 1999
Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary interventionG Dangas, J D Marmur, T E King, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|November 26, 2013
Clustering of acute and subacute stent thrombosis related to the introduction of generic clopidogrelJason C Kovacic, Roxana Mehran, Joseph Sweeny, et al.
Journal of the American College of Cardiology|March 27, 2001
Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbitsG Helft, S G Worthley, V Fuster, et al.
Pageof 27

Showing results (211-220 of 262) with videos related to

Sort By:
Pageof 27
Thrombosis and Haemostasis|December 7, 2017
Escitalopram Impairs Thrombin-Induced Platelet Response, Cytoskeletal Assembly and Activation of Associated Signalling PathwaysIrene Lopez-Vilchez, Didac Jerez-Dolz, Maribel Diaz-Ricart, et al.
Pathophysiology of Haemostasis and Thrombosis|March 12, 2008
Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosisStephen G Worthley, Gérard Helft, Roberto Corti, et al.
Circulation|February 4, 1997
Tissue factor modulates the thrombogenicity of human atherosclerotic plaquesV Toschi, R Gallo, M Lettino, et al.
The American Journal of Cardiology|July 29, 2000
In vivo demonstration of an antithrombin effect of abciximabJ A Ambrose, M Hawkey, J J Badimon, et al.
The British Journal of Cardiology|June 24, 2024
Metabolic syndrome components determine the presence of subclinical atherosclerosis in obese and overweightGustavo A Giunta, Pablo D Cutine, María F Aguiló Iztueta, et al.
Thrombosis and Haemostasis|May 24, 2000
Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effectG Dangas, D A Smith, A H Unger, et al.
The American Journal of Cardiology|September 25, 1999
Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatinG Dangas, D A Smith, J J Badimon, et al.
American Heart Journal|July 1, 1999
Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary interventionG Dangas, J D Marmur, T E King, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|November 26, 2013
Clustering of acute and subacute stent thrombosis related to the introduction of generic clopidogrelJason C Kovacic, Roxana Mehran, Joseph Sweeny, et al.
Journal of the American College of Cardiology|March 27, 2001
Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbitsG Helft, S G Worthley, V Fuster, et al.
Pageof 27